Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,587,951 papers from all fields of science
Search
Sign In
Create Free Account
SLC34A2 gene
Known as:
NAPI-3B
, Solute Carrier Family 34 (Sodium Phosphate), Member 2 Gene
, SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 2
Expand
This gene plays a role in phosphate transport.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Homo sapiens
Ionophore activity
Ligand Binding
Molecular Transport
Expand
Narrower (1)
SLC34A2 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy
Amber L Mueller
,
A. O’Neill
,
+8 authors
R. Bloch
Experimental Neurology
2019
Corpus ID: 195886913
2018
2018
Novel deletion of SLC34A2 in Chinese patients of PAM shares mutation hot spot with fusion gene SLC34A2–ROS1 in lung cancer
Dandan Shang
,
Chen Yuqin
,
+6 authors
Fengjun Tian
Journal Genetika
2018
Corpus ID: 52273281
Pulmonary alveolar microlithiasis (PAM) is an autosomal recessive disorder with distinctive deposition of calcium phosphate…
Expand
2017
2017
Effect of SLC34A2 gene mutation on extracellular phosphorus transport in PAM alveolar epithelial cells
Tiangang Ma
,
D. Qu
,
Bingdi Yan
,
Qinghua Zhang
,
Jin Ren
,
Yanbing Hu
Experimental and Therapeutic Medicine
2017
Corpus ID: 1721368
A mutation in the IIb sodium phosphate transporter SLC34A2 gene has recently been described in pulmonary alveolar microlithiasis…
Expand
2017
2017
A Case of Pulmonary Alveolar Microlithiasis Diagnosed by Transbronchial Biopsy.
Huseyin Arpag
,
M. Sayan
,
+4 authors
M. Tokur
Turkish Thoracic Journal
2017
Corpus ID: 44162703
Pulmonary alveolar microlithiasis is a rare infiltrative pulmonary disease, in which intraalveolar accumulation of small stones…
Expand
2016
2016
Diagnosis and treatment of pulmonary alveolar microlithiasis
N. Emiralioğlu
,
B. Beken
,
+5 authors
N. Kiper
Pediatrics International
2016
Corpus ID: 41472126
Pulmonary alveolar microlithiasis (PAM) is a rare genetic disease caused by mutations in sodium–phosphate co‐transporter (SLC34A2…
Expand
2015
2015
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: Presentation of an inbred family and a novel truncating mutation in exon 3
M. Vismara
,
E. Colao
,
+8 authors
N. Perrotti
Respiratory Medicine Case Reports
2015
Corpus ID: 548317
2015
2015
Up-Regulation of Intestinal Phosphate Transporter NaPi-IIb (SLC34A2) by the Kinases SPAK and OSR1
Myriam Fezai
,
B. Elvira
,
J. Warsi
,
M. Ben-Attia
,
Z. Hosseinzadeh
,
F. Lang
Kidney & Blood Pressure Research
2015
Corpus ID: 4865195
Background/Aims: SPAK (SPS1-related proline/alanine-rich kinase) and OSR1 (oxidative stress-responsive kinase 1), kinases…
Expand
2013
2013
Visualization of phosphatidylcholine (16:0/16:0) in type II alveolar epithelial cells in the human lung using imaging mass spectrometry
Nobuya Kurabe
,
T. Hayasaka
,
+14 authors
H. Sugimura
Pathology international (Print)
2013
Corpus ID: 30468774
Imaging mass spectrometry (MS) is an emerging technique that can detect numerous biomolecular distributions in a non‐targeting…
Expand
2010
2010
Mutations in the gene of human type IIb sodium-phosphate cotransporter SLC34A2
D. Lituiev
,
R. Kiyamova
2010
Corpus ID: 54733677
Type IIb sodium-phosphate cotransporter (NaPi2b) provides phosphate intake in the cells of some epithelial tissues, osteoblasts…
Expand
2005
2005
Monoclonal antibody MX 35 detects the membrane transporter NaPi 2 b ( SLC 34 A 2 ) in human carcinomas
B. W. Yin
,
R. Kiyamova
,
+14 authors
G. Ritter
2005
Corpus ID: 40894391
1Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, NY, USA 2The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE